| Over the past | Total investment | Would've become | Historic returns | Returns |
|---|---|---|---|---|
| 3 months | ₹15,000 | ₹16,016 | +6.77% | |
| 6 months | ₹30,000 | ₹32,705 | +9.02% | |
| 1 year | ₹60,000 | ₹65,632 | +9.39% |
| Name | Sector | Instruments | Assets |
|---|---|---|---|
| Lupin Ltd. | Healthcare | Equity | 9.88% |
| Fortis Healthcare Ltd. | Healthcare | Equity | 8.50% |
| Laurus Labs Ltd. | Healthcare | Equity | 7.57% |
| Aurobindo Pharma Ltd. | Healthcare | Equity | 6.86% |
| Glenmark Pharmaceuticals Ltd. | Healthcare | Equity | 6.40% |
| Alkem Laboratories Ltd. | Healthcare | Equity | 5.58% |
| Biocon Ltd. | Healthcare | Equity | 4.54% |
| Mankind Pharma Ltd. | Healthcare | Equity | 4.49% |
| Ipca Laboratories Ltd. | Healthcare | Equity | 3.76% |
| Aster DM Healthcare Ltd. | Healthcare | Equity | 3.14% |
| JB Chemicals & Pharmaceuticals Ltd. | Healthcare | Equity | 2.96% |
| Krishna Institute of Medical Sciences Ltd | Healthcare | Equity | 2.91% |
| Sai Life Sciences Ltd. | Healthcare | Equity | 2.60% |
| Gland Pharma Ltd. | Healthcare | Equity | 2.46% |
| Abbott India Ltd. | Healthcare | Equity | 2.34% |
| Neuland Laboratories Ltd. | Healthcare | Equity | 2.29% |
| Narayana Hrudayalaya Ltd. | Healthcare | Equity | 2.16% |
| Ajanta Pharma Ltd. | Healthcare | Equity | 2.10% |
| Wockhardt Ltd. | Healthcare | Equity | 2.04% |
| Dr. Lal Pathlabs Ltd. | Healthcare | Equity | 1.88% |
| Granules India Ltd. | Healthcare | Equity | 1.79% |
| Piramal Pharma Ltd. | Healthcare | Equity | 1.77% |
| Natco Pharma Ltd. | Healthcare | Equity | 1.74% |
| Glaxosmithkline Pharmaceuticals Ltd. | Healthcare | Equity | 1.71% |
| Onesource Specialty Pharma Ltd. | Healthcare | Equity | 1.70% |
| Global Health Ltd. | Healthcare | Equity | 1.67% |
| Syngene International Ltd. | Healthcare | Equity | 1.57% |
| Cohance Lifesciences Ltd. | Healthcare | Equity | 1.39% |
| Pfizer Ltd. | Healthcare | Equity | 1.26% |
| Poly Medicure Ltd. | Healthcare | Equity | 1.02% |
| Name | 3M | 6M | 1Y | All |
|---|---|---|---|---|
| Fund returns | +14.9% | +7.8% | +17.8% | +38.1% |
| Category average (Equity Sectoral) | -- | -- | -2.1% | -- |
| Rank (Equity Sectoral) | 1 | 5 | 7 | -- |